JTK-853 or Placebo

DRUG2 trials

Sponsors

Akros Pharma Inc.

Conditions

Healthy

Phase 1

Two Week Study Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Doses of JTK-853 in Healthy Subjects

TerminatedNCT01473069

Akros Pharma Inc.Healthy

Start: 2010-03-31End: 2010-07-31Updated: 2011-11-21

Safety, Tolerability and Pharmacokinetics Study Assessing Ascending Single Oral JTK-853 Doses in Healthy Subjects

CompletedNCT01475981

Akros Pharma Inc.Healthy

Start: 2010-01-31End: 2010-04-30Updated: 2011-11-22